We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPI
976
Farmland Partners
FPI
$420M
$19K ﹤0.01%
3,000
GBT
977
DELISTED
Global Blood Therapeutics, Inc.
GBT
$19K ﹤0.01%
358
+117
+49% +$5.75K
BRT
978
BRT Apartments
BRT
$283M
$18K ﹤0.01%
1,300
GRFS
979
Grifois
GRFS
$5.27B
$18K ﹤0.01%
874
+77
+10% +$1.47K
LGND icon
980
PUT
Ligand Pharmaceuticals
LGND
$5.96B
$17K ﹤0.01%
+160
New +$12.1K
ARGX icon
981
argenx
ARGX
$55.6B
$16K ﹤0.01%
132
-28
-18% -$3.29K
AZUL
982
DELISTED
Azul
AZUL
$16K ﹤0.01%
550
-150
-21% -$4.48K
LGND icon
983
Ligand Pharmaceuticals
LGND
$5.96B
$16K ﹤0.01%
208
+20
+11% +$1.51K
MRTX
984
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$16K ﹤0.01%
224
-38
-15% -$2.58K
AKCA
985
DELISTED
Akcea Therapeutics Inc
AKCA
$16K ﹤0.01%
568
-100
-15% -$2.91K
GHDX
986
DELISTED
Genomic Health, Inc.
GHDX
$16K ﹤0.01%
235
+43
+22% +$3.19K
HALO icon
987
Halozyme
HALO
$9.66B
$15K ﹤0.01%
922
+135
+17% +$2.19K
MYGN icon
988
Myriad Genetics
MYGN
$515M
$15K ﹤0.01%
466
+83
+22% +$2.53K
XLRN
989
DELISTED
Acceleron Pharma
XLRN
$15K ﹤0.01%
329
+79
+32% +$3.47K
PTLA
990
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$15K ﹤0.01%
422
+61
+17% +$1.76K
ZGNX
991
DELISTED
Zogenix, Inc.
ZGNX
$15K ﹤0.01%
268
+79
+42% +$3.76K
DNLI icon
992
Denali Therapeutics
DNLI
$3.74B
$14K ﹤0.01%
604
-161
-21% -$3.37K
INSM icon
993
Insmed
INSM
$22.7B
$14K ﹤0.01%
493
+70
+17% +$1.81K
PTCT icon
994
PTC Therapeutics
PTCT
$6.29B
$14K ﹤0.01%
365
+136
+59% +$4.57K
QURE icon
995
uniQure
QURE
$2.63B
$14K ﹤0.01%
+239
New +$10.7K
AERI
996
DELISTED
Aerie Pharmaceuticals
AERI
$14K ﹤0.01%
289
+86
+42% +$3.79K
ARNA
997
DELISTED
Arena Pharmaceuticals Inc
ARNA
$14K ﹤0.01%
315
-52
-14% -$2.38K
ANAB icon
998
AnaptysBio
ANAB
$1.59B
$13K ﹤0.01%
172
+42
+32% +$2.9K
MEDP icon
999
Medpace
MEDP
$16.5B
$13K ﹤0.01%
227
+19
+9% +$1.14K
RGNX icon
1000
Regenxbio
RGNX
$622M
$13K ﹤0.01%
232
+60
+35% +$2.97K

Similar funds

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.